Equities Analysts Issue Forecasts for Allstate Q2 Earnings

The Allstate Co. (NYSE:ALL - Free Report) - Zacks Research dropped their Q2 2025 earnings per share (EPS) estimates for Allstate in a research report issued to clients and investors on Monday, March 10th. Zacks Research analyst Z. Masood now expects that the insurance provider will post earnings per share of $3.04 for the quarter, down from their previous forecast of $3.08. The consensus estimate for Allstate's current full-year earnings is $18.74 per share. Zacks Research also issued estimates for Allstate's Q3 2025 earnings at $4.21 EPS, Q4 2025 earnings at $6.40 EPS, FY2025 earnings at $17.65 EPS, Q1 2026 earnings at $5.16 EPS, Q2 2026 earnings at $3.94 EPS, Q4 2026 earnings at $7.28 EPS and FY2026 earnings at $20.98 EPS.

Several other brokerages have also weighed in on ALL. Wells Fargo & Company lifted their price target on Allstate from $186.00 to $187.00 and gave the company an "equal weight" rating in a research note on Tuesday, January 14th. Evercore ISI raised Allstate from an "in-line" rating to an "outperform" rating in a research note on Wednesday, January 8th. Piper Sandler lifted their price target on shares of Allstate from $206.00 to $244.00 and gave the company an "overweight" rating in a research note on Tuesday, November 26th. The Goldman Sachs Group increased their price objective on shares of Allstate from $209.00 to $230.00 and gave the company a "buy" rating in a report on Friday, November 15th. Finally, Argus upgraded Allstate from a "hold" rating to a "buy" rating in a research note on Monday, March 3rd. One equities research analyst has rated the stock with a sell rating, one has assigned a hold rating, fifteen have assigned a buy rating and one has issued a strong buy rating to the company. According to MarketBeat, Allstate currently has a consensus rating of "Moderate Buy" and a consensus price target of $217.94.

Remove Ads

Allstate Stock Performance

ALL traded up $5.68 on Thursday, reaching $207.68. The stock had a trading volume of 2,546,006 shares, compared to its average volume of 1,524,794. The business's 50-day moving average price is $191.72 and its two-hundred day moving average price is $192.38. The company has a market cap of $55.04 billion, a P/E ratio of 12.22, a price-to-earnings-growth ratio of 1.01 and a beta of 0.47. Allstate has a 12-month low of $156.66 and a 12-month high of $209.88. The company has a current ratio of 0.36, a quick ratio of 0.40 and a debt-to-equity ratio of 0.42.

Allstate (NYSE:ALL - Get Free Report) last issued its quarterly earnings data on Wednesday, February 5th. The insurance provider reported $7.67 EPS for the quarter, topping analysts' consensus estimates of $5.40 by $2.27. Allstate had a net margin of 7.28% and a return on equity of 28.20%.

Allstate announced that its Board of Directors has authorized a share buyback plan on Wednesday, February 26th that allows the company to repurchase $1.50 billion in shares. This repurchase authorization allows the insurance provider to repurchase up to 3% of its shares through open market purchases. Shares repurchase plans are generally a sign that the company's management believes its shares are undervalued.

Allstate Increases Dividend

The company also recently declared a quarterly dividend, which will be paid on Tuesday, April 1st. Stockholders of record on Monday, March 10th will be paid a dividend of $1.00 per share. This represents a $4.00 dividend on an annualized basis and a dividend yield of 1.93%. This is a positive change from Allstate's previous quarterly dividend of $0.92. The ex-dividend date of this dividend is Monday, March 10th. Allstate's payout ratio is 23.54%.

Insider Activity

In other news, CFO Jesse E. Merten sold 40,102 shares of Allstate stock in a transaction dated Monday, February 10th. The shares were sold at an average price of $186.53, for a total transaction of $7,480,226.06. Following the completion of the sale, the chief financial officer now directly owns 18,115 shares in the company, valued at $3,378,990.95. The trade was a 68.88 % decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is available through the SEC website. Insiders own 1.80% of the company's stock.

Institutional Trading of Allstate

A number of institutional investors and hedge funds have recently bought and sold shares of ALL. United Bank acquired a new position in Allstate during the 3rd quarter worth $209,000. Apollon Wealth Management LLC boosted its position in Allstate by 2.7% during the 3rd quarter. Apollon Wealth Management LLC now owns 5,901 shares of the insurance provider's stock worth $1,119,000 after acquiring an additional 157 shares during the period. Entropy Technologies LP acquired a new position in Allstate during the 3rd quarter valued at about $284,000. Harbour Investments Inc. raised its holdings in Allstate by 5.4% during the third quarter. Harbour Investments Inc. now owns 2,503 shares of the insurance provider's stock worth $475,000 after purchasing an additional 128 shares in the last quarter. Finally, WealthPlan Investment Management LLC bought a new position in Allstate during the 3rd quarter valued at $208,000. Institutional investors and hedge funds own 76.47% of the company's stock.

Allstate Company Profile

The Allstate Corporation, together with its subsidiaries, provides property and casualty, and other insurance products in the United States and Canada. It operates in five segments: Allstate Protection; Protection Services; Allstate Health and Benefits; Run-off Property-Liability; and Corporate and Other segments.